Radiopharm Theranostics LimitedASX: RAD

Target market determination (TMD)

· Issued by Radiopharm Theranostics Limited via ASX

Filed with ASX ·

TARGET MARKET DETERMINATION MADE BY: RADIOPHARM THERANOSTICS LIMITED (ACN 647 877 889) of Suite 1, Level 3, 62 Lygon Street, Carlton South, VIC 3053 ( Company ) PRODUCT: Subject to shareholder approval, free attaching options ( Attaching Options ) in connection with an offer of shares...

View Attachment

6ix hasn’t read this filing yet.

Radiopharm Theranostics Limited on 6ix

Earlier from Radiopharm Theranostics

Later from Radiopharm Theranostics

All Radiopharm Theranostics news releases